Trials / Completed
CompletedNCT00192361
Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)
A Randomized, Double-Blind Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- MedImmune LLC · Industry
- Sex
- All
- Age
- 8 Months – 36 Months
- Healthy volunteers
- Accepted
Summary
To assess whether CAIV-T was transmitted from vaccinated children to their unvaccinated contacts in a day care setting; and if so, to estimate the rate of transmission.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CAIV-T |
Timeline
- Start date
- 1999-11-01
- First posted
- 2005-09-19
- Last updated
- 2006-10-25
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT00192361. Inclusion in this directory is not an endorsement.